Fmoc-S-tert.butyl-D-cysteine

Fmoc-S-tert.butyl-D-cysteine is an Fmoc-protected, D-configured cysteine derivative in which the thiol side chain is masked as a tert-butyl thioether (S-tert-butyl), while the amino acid backbone retains the carboxylic acid functionality for coupling chemistry. The molecule contains an N-terminal fluorenylmethyloxycarbonyl (Fmoc) protecting group on the amino group and a side-chain sulfur substituent that modulates nucleophilicity and chemoselectivity during peptide assembly. In peptide synthesis workflows, this protected analogue is used as a stepwise building block to introduce a cysteine-derived residue with controlled thiol reactivity, supporting preparation of peptides and peptide conjugates where side-chain protection is required for compatibility with other functional groups.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP00633

CAS No:131766-22-8

Synonyms/Alias:131766-22-8;FMOC-D-CYS(TBU)-OH;FMOC-S-TERT-BUTYL-D-CYSTEINE;D-Cysteine,S-(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-;Fmoc-S-t-butyl-D-cysteine;Fmoc-(S)-tert-butyl-D-Cys;Fmoc-S-tert.butyl-D-cysteine;SCHEMBL1491454;CTK4B7499;IXAYZHCPEYTWHW-LJQANCHMSA-N;ZINC1576231;AKOS015837435;AM81674;RTR-004364;AC-19293;AK170018;KB-52157;AB0108160;AB1006959;TR-004364;FT-0643157;Z-0033;A806311;I14-26587;(2S)-3-(tert-butylsulfanyl)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}propanoicacid

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C22H25NO4S
M.W/Mr.
399.5

Fmoc-S-tert.butyl-D-cysteine is an Fmoc-protected D-cysteine derivative in which the thiol side chain is masked as an S-tert-butyl thioether, giving a stable chiral amino acid building block with a protected N-terminus and a protected sulfur functionality. The molecule contains a carbamate-linked Fmoc group on the amino nitrogen, a free carboxylate-reactive acid functionality suitable for peptide coupling after activation, and a stereogenic center at the alpha carbon that preserves D-configuration during downstream synthesis. The tert-butyl thioether protecting group is designed to tolerate peptide coupling conditions while enabling controlled sulfur deprotection under acid-labile strategies, producing a cysteine thiol equivalent for further functionalization. This combination of an N-protecting Fmoc group and a thiol-protecting S-tert-butyl group positions the compound as a practical intermediate for peptide assembly, disulfide engineering, and sulfur-based derivatization in both research and industrial settings.

1. Fmoc Peptide Synthesis

Fmoc-S-tert.butyl-D-cysteine is used in Fmoc-based solid-phase peptide synthesis where the Fmoc carbamate enables orthogonal N-deprotection to generate a reactive amino site for sequential coupling. The D-configured alpha-amino acid framework and the carboxylic acid functionality support standard peptide coupling chemistry, while the S-tert-butyl thioether protects the sulfur from undesired side reactions during chain elongation. Controlled thiol unveiling after peptide assembly can generate a cysteine thiol handle for disulfide bond formation, thioether formation, or selective conjugation strategies. The resulting D-cysteine-containing peptide products can be used to probe stereochemical effects in peptide structure, folding constraints, and sulfur-dependent recognition motifs.

2. Side-Chain Sulfur Functionalization

Fmoc-S-tert.butyl-D-cysteine is suitable for side-chain functionalization workflows that require a protected cysteine equivalent for late-stage sulfur chemistry. The masked thiol functionality allows manipulation of the sulfur oxidation state and connectivity after deprotection, enabling conversion to disulfides, thioethers, sulfonamides, or thioester-like intermediates depending on the chosen downstream transformation. The retained D-stereochemistry can be leveraged to construct enantiomerically defined peptide analogs and to evaluate how sulfur stereochemistry influences conformational preferences and binding-site complementarity. Sulfur-functionalized derivatives derived from this building block can serve as intermediates for chemical biology probes, protein labeling reagents, and peptidomimetic scaffolds.

3. Chemical Biology Labeling

Fmoc-S-tert.butyl-D-cysteine supports chemical biology and biomolecule labeling strategies that rely on cysteine-thiol reactivity after controlled deprotection. The Fmoc-protected amino group and thiol-protected sulfur enable stepwise synthesis of labeled peptides or conjugation-ready fragments with reduced risk of premature thiol oxidation during handling and purification. D-cysteine incorporation can be applied when stereochemical control is required for probe specificity, resistance to proteolysis, or alignment with binding pockets that discriminate stereochemistry. Downstream conjugates prepared from the deprotected thiol can be used to generate defined thioether or disulfide-linked biomolecular constructs for mechanistic studies and reagent development.

4. Peptidomimetics And SAR Studies

Fmoc-S-tert.butyl-D-cysteine is applied in peptidomimetic construction and structure-activity relationship studies where cysteine side-chain placement and sulfur chemistry are key variables. The compound's chiral D-cysteine backbone provides a stereochemically defined handle for building analog libraries that vary sulfur connectivity, oxidation state, or conjugation pattern while keeping the alpha-carbon configuration constant. The orthogonal protection scheme, with Fmoc on nitrogen and S-tert-butyl on sulfur, supports systematic derivatization workflows that separate peptide assembly from final sulfur installation. Peptidomimetic analogs generated through this approach can function as SAR tool compounds, enabling comparison of how D-cysteine stereochemistry and sulfur functionality influence molecular recognition and stability in synthetic screening campaigns.

5. Pharmaceutical Intermediate Preparation

Fmoc-S-tert.butyl-D-cysteine is relevant to pharmaceutical intermediate preparation and fine chemical synthesis routes that require protected amino acid building blocks for controlled incorporation into larger molecules. The Fmoc carbamate and acid-reactive carboxyl functionality support reproducible coupling steps, while the acid-labile S-tert-butyl sulfur protection strategy can be aligned with manufacturing sequences that separate peptide or fragment assembly from final thiol generation. D-cysteine stereochemistry can be important for producing stereodefined intermediates used in the synthesis of peptide-like active ingredients, inhibitor fragments, or sulfur-containing pharmacophores. The compound therefore serves as a practical chiral amino acid intermediate for downstream manufacturing of protected and selectively deprotected sulfur-containing structures.

Abbr
Fmoc-D-Cys(tBu)-OH
InChI
1S/C22H25NO4S/c1-22(2,3)28-13-19(20(24)25)23-21(26)27-12-18-16-10-6-4-8-14(16)15-9-5-7-11-17(15)18/h4-11,18-19H,12-13H2,1-3H3,(H,23,26)(H,24,25)/t19-/m1/s1
InChI Key
IXAYZHCPEYTWHW-LJQANCHMSA-N
Canonical SMILES
CC(C)(C)SCC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisEpitope Mapping ServicesPeptide Analysis ServicescGMP Peptide ServiceCustom Conjugation ServicePeptide Synthesis ServicesPeptide CDMOPeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers